Total Payments
$2,449
2024 Payments
$280.25
Companies
25
Transactions
148
Medicare Patients
7,132
Medicare Billing
$651,397
Payment Breakdown by Category
Food & Beverage$2,366 (96.6%)
Education$82.99 (3.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,366 | 147 | 96.6% |
| Education | $82.99 | 1 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $370.60 | 18 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $345.04 | 21 | $0 (2023) |
| PFIZER INC. | $290.59 | 24 | $0 (2024) |
| Amgen Inc. | $185.47 | 12 | $0 (2022) |
| Arbor Pharmaceuticals, Inc. | $175.33 | 10 | $0 (2017) |
| Lexicon Pharmaceuticals, Inc. | $174.39 | 10 | $0 (2024) |
| Astellas Pharma US Inc | $154.77 | 5 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $94.34 | 8 | $0 (2023) |
| Allergan Inc. | $81.64 | 5 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $77.94 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $280.25 | 15 | Lexicon Pharmaceuticals, Inc. ($112.19) |
| 2023 | $227.75 | 13 | Novartis Pharmaceuticals Corporation ($69.12) |
| 2022 | $292.56 | 18 | Boehringer Ingelheim Pharmaceuticals, Inc. ($94.48) |
| 2021 | $101.72 | 6 | Boehringer Ingelheim Pharmaceuticals, Inc. ($72.38) |
| 2020 | $88.43 | 5 | AbbVie Inc. ($40.83) |
| 2019 | $181.43 | 12 | Amgen Inc. ($57.65) |
| 2018 | $274.30 | 20 | Boehringer Ingelheim Pharmaceuticals, Inc. ($76.91) |
| 2017 | $1,003 | 59 | Novartis Pharmaceuticals Corporation ($197.12) |
All Payment Transactions
148 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Cardio-renal | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/05/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.40 | General |
| 08/23/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.19 | General |
| 08/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Cardio-renal | ||||||
| 07/01/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.21 | General |
| 06/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Obesity | ||||||
| 06/05/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.93 | General |
| 05/30/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.39 | General |
| 04/30/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/17/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Diabetes | ||||||
| 04/03/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.07 | General |
| 02/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/26/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 12/06/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 10/26/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/15/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 07/26/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 07/17/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 07/13/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/16/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: DIABETES | ||||||
| 04/20/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/18/2023 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 02/23/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,623 | 1,885 | $754,323 | $155,036 |
| 2022 | 25 | 1,799 | 2,109 | $643,471 | $167,858 |
| 2021 | 26 | 1,934 | 2,297 | $662,222 | $186,626 |
| 2020 | 23 | 1,776 | 2,059 | $555,036 | $141,878 |
Total Patients
7,132
Total Services
8,350
Medicare Billing
$651,397
Procedure Codes
105
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 39 | 39 | $220,854 | $42,514 | 19.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 411 | 474 | $175,380 | $36,530 | 20.8% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 39 | 78 | $73,944 | $18,255 | 24.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 182 | 184 | $46,368 | $8,810 | 19.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 183 | 183 | $46,116 | $8,748 | 19.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 54 | 60 | $29,760 | $7,418 | 24.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 39 | 156 | $30,264 | $6,887 | 22.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $24,123 | $4,565 | 18.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 48 | 49 | $22,932 | $4,314 | 18.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 44 | 65 | $16,185 | $3,794 | 23.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 52 | 52 | $14,092 | $2,949 | 20.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $10,575 | $2,203 | 20.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 36 | 36 | $10,548 | $1,899 | 18.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 32 | 32 | $8,672 | $1,806 | 20.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 104 | 104 | $7,592 | $989.17 | 13.0% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 40 | 40 | $3,600 | $752.50 | 20.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 100 | 111 | $3,885 | $700.75 | 18.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 64 | 66 | $3,366 | $675.40 | 20.1% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 31 | 31 | $2,387 | $489.30 | 20.5% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 19 | 19 | $1,824 | $365.37 | 20.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 32 | 32 | $1,632 | $334.80 | 20.5% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 16 | 16 | $224.00 | $38.08 | 17.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 481 | 614 | $172,196 | $47,625 | 27.7% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2022 | 33 | 33 | $107,552 | $35,772 | 33.3% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2022 | 33 | 66 | $65,272 | $15,261 | 23.4% |
About Dr. Michael Holman, MD
Dr. Michael Holman, MD is a Specialist healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1598960619.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Holman, MD has received a total of $2,449 in payments from pharmaceutical and medical device companies, with $280.25 received in 2024. These payments were reported across 148 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,366).
As a Medicare-enrolled provider, Holman has provided services to 7,132 Medicare beneficiaries, totaling 8,350 services with total Medicare billing of $651,397. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Cardiovascular Disease
- Location Augusta, GA
- Active Since 06/19/2007
- Last Updated 12/27/2023
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1598960619
Products in Payments
- ENTRESTO (Drug) $250.27
- JARDIANCE (Drug) $240.20
- ELIQUIS (Drug) $205.60
- CHANTIX (Drug) $179.33
- LEQVIO (Drug) $120.33
- PRADAXA (Drug) $104.84
- Edarbi (Drug) $102.38
- Repatha (Biological) $97.11
- LINZESS (Drug) $88.82
- Corlanor (Drug) $88.36
- Edarbyclor (Drug) $72.95
- PRALUENT (Drug) $66.25
- Inpefa (Drug) $62.20
- BRILINTA (Drug) $62.18
- LEXISCAN (Drug) $54.76
- MITRACLIP (Device) $41.89
- Ozempic (Drug) $39.95
- ZONTIVITY (Drug) $39.34
- WATCHMAN FLX (Device) $38.24
- XARELTO (Drug) $36.98
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Augusta
Dr. David Zabel, M.d, M.D
Specialist — Payments: $560,294
Specialist $560,294
Dr. Samir Khleif, M.d, M.D
Specialist — Payments: $275,212
Specialist $275,212
Dr. Sharad Ghamande, M.d, M.D
Specialist — Payments: $251,896
Specialist $251,896
Dr. Richard Epter, M.d.,Dabpm,Fipp, M.D.,DABPM,FIPP
Specialist — Payments: $28,835
Specialist $28,835
Grace Pilcher, Md, MD
Specialist — Payments: $12,003
Specialist $12,003
Bimal Shah, Md, MD
Specialist — Payments: $8,697
Specialist $8,697